TALK KEYWORD INDEX
This page contains an index consisting of author-provided keywords.
1 | |
1H MRS | |
3 | |
3D-conformal radiation therapy | |
A | |
aa | |
ACE inhibition | |
advanced tumor models | |
aging | |
alanine | |
Anti-PD-L1 | |
artificial intelligence | |
Atlas | |
B | |
bb | |
BDSIM | |
bioluminescence | |
Biomarkers | |
brain tumors | |
breast cancer | |
bystander effect | |
C | |
cachexia | |
Cancer | |
canines | |
cardiac | |
Cardiac strain | |
cardiopulmonary system | |
Cardiotoxicity | |
CB-CT imaging | |
cc | |
cell cycle | |
Cell specific analyses | |
Cesium | |
chemoradiotherapy | |
chemotherapy | |
CIRP | |
Clinical trials | |
clonogenic survival | |
collagen | |
Combination therapies | |
Commissioning | |
Computed Tomography | |
contrast-enhanced computed tomography | |
cross centre comparison | |
D | |
deep learning | |
deterministic dose engine | |
DNA damage response pathway | |
Dose verification | |
dosimetric uncertainties | |
Dosimetry | |
Dosimetry audits | |
Dosimetry intercomparisons | |
draining lymph node irradiation | |
E | |
Early detection | |
eMRI/electron paramagnetic resonance imaging | |
F | |
fat loss | |
FLASH | |
FLASH radiation | |
FLASH-RT | |
Fractionated | |
fractionation | |
G | |
Geometric distortion | |
Glioblastoma | |
glioma | |
Gradient non-linearity | |
H | |
head and neck | |
Head and Neck Cancer | |
Hepatocellular Carcinoma | |
high-precision irradiation | |
histology | |
I | |
image guided irradiation | |
Image registration | |
image-guidance | |
image-guided brain irradiation | |
Image-guided mouse irradiation | |
Image-guided radiation | |
Imaging biomarkers | |
Immune Infiltration | |
Immunology | |
immunotherapy | |
In-Vivo | |
in-vivo proton irradiation | |
Inflammation | |
intensity-modulated radiation therapy | |
intestinal | |
Intestinal stem cells | |
Ionoacoustics | |
K | |
k1 | |
k2 | |
k3 | |
L | |
Late effects | |
Linac | |
long-term | |
Long-term normal tissue toxicity | |
lung cancer | |
M | |
Magnetic field inhomogeneity | |
Magnetic Resonance | |
Magnetic Resonance Imaging | |
MALDI imaging | |
Mechanical accuracy | |
mesenchymal | |
Metastasis | |
metastatic tumor model | |
Mice | |
Micro-CT | |
Microbeam radiation therapy | |
Mini-beam | |
Minibeam | |
Minibeam radiation Therapy | |
mitotic enrichment | |
Molecular Dosimetry | |
Monte Carlo | |
monte carlo dose calculations | |
Monte Carlo simulations | |
Mouse brain proton irradiation | |
Mouse models | |
mouse organ segmentation | |
Mouse phantom | |
muscle loss | |
N | |
nanoparticle delivery | |
neurogenic regions | |
Neuroinflammation | |
normal brain tissue | |
Normal tissue | |
normal tissue biology | |
Normal tissue complications | |
Normal tissue effects | |
normal tissue models | |
novel combination treatment approaches | |
O | |
organic nanoparticle + radiotherapy | |
orthotopic | |
Orthotopic glioblastoma models | |
orthotopic mouse model | |
orthotopic tumor | |
orthotopic xenotransplant | |
Oxygen guided radiotherapy | |
Oxygen imaging | |
oxygen-guided radiotherapy | |
P | |
Paediatric brain cancer | |
pancreatic cancer | |
passive and active detectors | |
PBS | |
pencil beam | |
PET imaging | |
phantoms | |
positioning | |
precision delivery | |
preclinical | |
Preclinical (in vivo) studies | |
preclinical models | |
Preclinical mouse studies | |
preclinical proton research | |
preclinical radiation research dosimetry | |
preclinical radiotherapy | |
preclinical treatment planning | |
proton | |
proton dose distribution | |
proton facility | |
proton FLASH | |
Proton therapy | |
protons | |
Q | |
Quality assurance | |
R | |
Radiation | |
Radiation protection | |
Radiation response | |
radiation-induced injury | |
Radiation-induced myocardial fibrosis | |
Radiobiology | |
radiodynamic therapy | |
radioimmunotherapy | |
Radioluminescence | |
Radiomics | |
radioresistance | |
radioresistant tumors | |
radiosensitization | |
Radiotherapy | |
radiotherapy-induced lymphopenia | |
Real-time | |
RECIST | |
recovery | |
Registration | |
Relative biological effectiveness (RBE) | |
reliability | |
research facility | |
S | |
SARRP | |
SARRP FLASH | |
SFRT | |
side-effects | |
SIRMIO | |
skin | |
small animal | |
Small animal IGRT | |
Small animal irradiator | |
Small animal radiotherapy | |
Small-animal radiotherapy | |
Spatial resolution | |
standardisation | |
stereotactic ablative radiotherapy | |
stiffness | |
Subvolume | |
syngeneic animal model | |
T | |
T cells | |
Temporal and Spatial Factors | |
Thermoluminescent Dosimeter | |
thoracic radiotherapy | |
TLD Fading with Temperature | |
TLD-100 behavior | |
tomography | |
Traceability | |
translational | |
Treatment planning | |
Treatment Planning System | |
treatment verification | |
Tumor control | |
Tumor hypoxia | |
Tumour | |
Tumour heterogeneity | |
U | |
Ultra-high dose radiation | |
Ultra-high dose rate | |
Ultra-high field | |
V | |
VEGF-A | |
W | |
workflow | |
working parties | |
X | |
x-ray | |
Xenograft |